InfuSystemsvsMerck & Company

INFU and MRK stock compared: price, dividend, valuation and results, from SEC filings.

INFU

InfuSystems Holdings, Inc.

$14.67

Value $297M

+0.00%
INFU's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-0.75%
MRK's page

InfuSystems (INFU) has a market value of $297M and Merck & Company (MRK) $341B. Over the last year, with dividends, INFU moved +55.5% and MRK +58.8%. The P/E is 31.4 for INFU and 138.9 for MRK. Dividend yield: INFU none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INFU$297M

    MRK$341B

    MRK is 1,149 times INFU

  • Revenue, 12 months

    INFU$144M

    MRK$67.4B

    MRK is 466 times INFU

  • Net income, 12 months

    INFU$9.4M

    MRK$2.5B

    MRK is 260 times INFU

  • Operating margin

    INFU9.8%

    MRK–

  • ROIC

    INFU12.7%

    MRK3.9%

    8.8 points apart

  • P/E

    INFU31.4

    MRK138.9

    MRK is 4.4 times INFU

  • Dividend yield

    INFU0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    INFU-16.8%

    MRK+98.6%

    115.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INFU-16.8%

MRK+98.6%

10020020222023202420252026
Returns by period
PeriodINFUWith dividendsMRKWith dividends
1 year since November 14, 2025+55.5%Price +55.5%+58.8%Price +54.3%
3 years since November 17, 2023+59.2%+16.8% a yearPrice +59.2%+54.4%+15.6% a yearPrice +40.9%
5 years since November 16, 2021-16.8%-3.6% a yearPrice -16.8%+98.6%+14.7% a yearPrice +70.5%
10 years since November 18, 2016+721.7%+23.4% a yearPrice +721.7%+229.5%+12.7% a yearPrice +142.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INFUInfuSystemsMRKMerck & Company

Valuation

INFUMRK
Valuation
Price$14.67$137.78
Market value$297M$341B
Enterprise value (EV)$307M$385B
P/E31.4138.9
P/E, 5-year median–14.8
P/B4.67.6
EV/EBIT21.680.8
Free cash flow yield8.4%4.3%

Results and growth

INFUMRK
Results and growth
Revenue, 12 months$144M$67.4B
Net income, 12 months$9.4M$2.5B
Free cash flow, 12 months$25M$14.7B
Earnings per share, 12 months$0.44$0.98
Revenue growth, year on year6.4%1.3%
Revenue growth a year, past+8.1%over 5 years+9.4%over 5 years
EPS growth a year, past-17.3%over 5 years+21.2%over 5 years

Margins and returns on capital

INFUMRK
Margins and returns on capital
Gross margin57.6%71.8%
Operating margin9.8%–
Net margin6.5%3.6%
ROIC12.7%3.9%
ROE16.0%5.2%

Balance sheet

INFUMRK
Balance sheet
Cash$9.1M$9.7B
Total debt$24M$53.8B
Net debt / EBITDA0.45.7
Interest cover13.8×2.4×

Dividends and buybacks

INFUMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield3.3%1.5%
Shareholder yield3.3%4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INFU or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, InfuSystems or Merck & Company?

By market value, Merck & Company ($341B) is about 1,148.7 times InfuSystems ($297M), at today's prices.

How did INFU and MRK stock do over the last 10 years?

Since November 18, 2016, INFU's price moved +721.7% and MRK's +142.8%. With dividends: INFU +721.7% (+23.4% a year), MRK +229.5% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, INFU or MRK?

The dividend yield at today's price is none for InfuSystems and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of INFU and MRK?

At today's price, the P/E is 31.4 for INFU and 138.9 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, InfuSystems or Merck & Company?

Over the last twelve months, the net margin was 6.5% for InfuSystems and 3.6% for Merck & Company, and the operating margin 9.8% and –. Revenue was $144M and $67.4B.

Which is the better investment, InfuSystems or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.